Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW FORT

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1760801039
CMS profile
2786442
Location
BIRMINGHAM, AL

General Payments · PY2018–2024

$5,314.96

  • Reported across 100 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,029.57

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,029.57 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Cochlear Americas $296.96 10
GENZYME CORPORATION $187.68 5
GlaxoSmithKline, LLC. $166.38 9
AERIN MEDICAL INC. $136.00 1
Regeneron Healthcare Solutions, Inc. $112.72 4
Smith & Nephew, Inc. $81.93 3
MED-EL Corporation $31.40 1
OptiNose US, Inc. $16.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $31.23 2
PY2019 $440.96 5
PY2020 $25.00 1
PY2021 $49.30 3
PY2022 $545.50 25
PY2023 $3,193.40 30
PY2024 $1,029.57 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AERIN MEDICAL INC. $136.00 05/15/2024 Food and Beverage Undisputed 01/23/2026 1144645699 CMS
Cochlear Americas $14.22 01/09/2024 Food and Beverage Undisputed 01/23/2026 1128590404 CMS
Cochlear Americas $148.06 05/03/2024 Food and Beverage Undisputed 01/23/2026 1128590392 CMS
Cochlear Americas $24.77 05/03/2024 Food and Beverage Undisputed 01/23/2026 1128590396 CMS
Cochlear Americas $18.52 05/03/2024 Food and Beverage Undisputed 01/23/2026 1128590402 CMS
Cochlear Americas $4.72 05/03/2024 Food and Beverage Undisputed 01/23/2026 1128590408 CMS
Cochlear Americas $21.25 05/04/2024 Food and Beverage Undisputed 01/23/2026 1128590400 CMS
Cochlear Americas $8.08 05/04/2024 Food and Beverage Undisputed 01/23/2026 1128590406 CMS
Cochlear Americas $0.59 05/04/2024 Food and Beverage Undisputed 01/23/2026 1128590410 CMS
Cochlear Americas $34.30 05/06/2024 Food and Beverage Undisputed 01/23/2026 1128590394 CMS
Cochlear Americas $22.45 12/14/2024 Food and Beverage Undisputed 01/23/2026 1128590398 CMS
GENZYME CORPORATION $37.35 03/12/2024 Food and Beverage Undisputed 01/23/2026 1139784735 CMS
GENZYME CORPORATION $26.60 04/02/2024 Food and Beverage Undisputed 01/23/2026 1139784739 CMS
GENZYME CORPORATION $35.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 1139784763 CMS
GENZYME CORPORATION $44.02 07/23/2024 Food and Beverage Undisputed 01/23/2026 1139784811 CMS
GENZYME CORPORATION $44.15 08/13/2024 Food and Beverage Undisputed 01/23/2026 1139784791 CMS
GlaxoSmithKline, LLC. $10.81 01/05/2024 Food and Beverage Undisputed 01/23/2026 1116494632 CMS
GlaxoSmithKline, LLC. $18.74 02/08/2024 Food and Beverage Undisputed 01/23/2026 1116359636 CMS
GlaxoSmithKline, LLC. $19.07 03/06/2024 Food and Beverage Undisputed 01/23/2026 1116134802 CMS
GlaxoSmithKline, LLC. $18.40 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116719068 CMS
GlaxoSmithKline, LLC. $17.59 05/30/2024 Food and Beverage Undisputed 01/23/2026 1115792096 CMS
GlaxoSmithKline, LLC. $16.61 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116197127 CMS
GlaxoSmithKline, LLC. $24.30 09/13/2024 Food and Beverage Undisputed 01/23/2026 1116458899 CMS
GlaxoSmithKline, LLC. $18.84 10/08/2024 Food and Beverage Undisputed 01/23/2026 1116581213 CMS
GlaxoSmithKline, LLC. $22.02 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116594900 CMS
MED-EL Corporation $31.40 04/16/2024 Food and Beverage Undisputed 01/23/2026 1147638987 CMS
Optinose US, Inc. $16.50 04/03/2024 Food and Beverage Undisputed 01/23/2026 1142193714 CMS
Regeneron Healthcare Solutions, Inc. $26.40 01/04/2024 Food and Beverage Undisputed 01/23/2026 1114049324 CMS
Regeneron Healthcare Solutions, Inc. $27.93 07/18/2024 Food and Beverage Undisputed 01/23/2026 1114049326 CMS
Regeneron Healthcare Solutions, Inc. $30.36 09/03/2024 Food and Beverage Undisputed 01/23/2026 1114049328 CMS
Regeneron Healthcare Solutions, Inc. $28.03 10/15/2024 Food and Beverage Undisputed 01/23/2026 1114049330 CMS
Smith+Nephew, Inc. $28.11 02/28/2024 Food and Beverage Undisputed 01/23/2026 1149569163 CMS
Smith+Nephew, Inc. $27.81 03/20/2024 Food and Beverage Undisputed 01/23/2026 1149569161 CMS
Smith+Nephew, Inc. $26.01 06/10/2024 Food and Beverage Undisputed 01/23/2026 1149569159 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.